-
A recent study shows that finasteride (Proscar) prevents or delays the appearance of prostate cancer. The drug, however, also shows sexual side effects and an increased risk of high-grade prostate cancer.
-
Omeprazole (Prilosec) approved for OTC heartburn treatment; Recall includes all repacked atorvastatin products; Paroxetine (Paxil) should not be used in children; FDA announces pilot program to post warning letter responses
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
-
In other legislation favorable to pharmacists, the Senate Committee on Health, Education, Labor, and Pensions recently passed a bipartisan bill that would provide two student loan repayment programs for certain pharmacists. The bill now moves on to the Senate floor for consideration.
-
Almotriptan malate (Axert) a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, otherwise known as a triptan, was approved by the U.S. Food and Drug Administration (FDA) in May 2001.
-
In the Pipeline
-
As experienced physicians understand, heart failure can be a difficult diagnosis to establish in the emergency department setting, especially when there are factors that may complicate a patients presentation. This issue of Emergency Medicine Reports reviews the role and clinical utility of brain natriuretic peptide in the management of patients suspected of having heart failure upon presentation to the ED
-
-
In the summer of 1971, Philip Zimbardo, PhD, was lead investigator on The Stanford Prison Experiment, a study designed to measure the psychological effects that imprisonment and authority would have on participants.
